Gabelli Funds LLC acquired a new position in shares of Mazor Robotics Ltd – (NASDAQ:MZOR) in the third quarter, HoldingsChannel reports. The firm acquired 230,043 shares of the medical instruments supplier’s stock, valued at approximately $13,416,000.

A number of other large investors also recently bought and sold shares of MZOR. LPL Financial LLC raised its position in Mazor Robotics by 39.0% during the first quarter. LPL Financial LLC now owns 7,789 shares of the medical instruments supplier’s stock worth $478,000 after acquiring an additional 2,185 shares during the period. Royal Bank of Canada raised its position in Mazor Robotics by 2.5% during the first quarter. Royal Bank of Canada now owns 65,319 shares of the medical instruments supplier’s stock worth $4,008,000 after acquiring an additional 1,606 shares during the period. Atria Investments LLC raised its position in Mazor Robotics by 26.8% during the second quarter. Atria Investments LLC now owns 5,312 shares of the medical instruments supplier’s stock worth $295,000 after acquiring an additional 1,122 shares during the period. Moody Lynn & Lieberson LLC acquired a new position in Mazor Robotics during the second quarter worth $414,000. Finally, Cookson Peirce & Co. Inc. raised its position in Mazor Robotics by 9.4% during the second quarter. Cookson Peirce & Co. Inc. now owns 18,960 shares of the medical instruments supplier’s stock worth $1,052,000 after acquiring an additional 1,635 shares during the period. Institutional investors own 21.71% of the company’s stock.

A number of research firms have weighed in on MZOR. Zacks Investment Research cut shares of Mazor Robotics from a “hold” rating to a “sell” rating in a research report on Wednesday, July 18th. BidaskClub raised shares of Mazor Robotics from a “hold” rating to a “buy” rating in a report on Saturday, September 22nd. Needham & Company LLC reaffirmed a “hold” rating on shares of Mazor Robotics in a report on Wednesday. Finally, ValuEngine raised shares of Mazor Robotics from a “hold” rating to a “buy” rating in a report on Friday, September 7th. One equities research analyst has rated the stock with a sell rating, four have assigned a hold rating, two have given a buy rating and one has given a strong buy rating to the company’s stock. Mazor Robotics presently has an average rating of “Hold” and a consensus price target of $59.90.

Mazor Robotics stock opened at $58.32 on Friday. Mazor Robotics Ltd – has a 52-week low of $41.60 and a 52-week high of $76.56. The firm has a market cap of $1.53 billion, a PE ratio of -116.64 and a beta of 1.32.

COPYRIGHT VIOLATION NOTICE: “Gabelli Funds LLC Buys New Position in Mazor Robotics Ltd – (MZOR)” was originally reported by Daily Political and is owned by of Daily Political. If you are viewing this piece on another site, it was copied illegally and republished in violation of United States and international trademark and copyright laws. The correct version of this piece can be viewed at https://www.dailypolitical.com/2018/11/10/gabelli-funds-llc-buys-new-position-in-mazor-robotics-ltd-mzor.html.

Mazor Robotics Profile

Mazor Robotics Ltd., together with its subsidiaries, engages in the development, production, and marketing of medical devices for supporting surgical procedures in the fields of orthopedics and neurosurgery in the United States and internationally. It operates in the field of computer assisted surgery that enable the use of surgical instruments with high precision and minimal invasiveness and that simplifies complex surgical procedures.

Further Reading: How Do Tariffs Affect Trade Balances?

Want to see what other hedge funds are holding MZOR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Mazor Robotics Ltd – (NASDAQ:MZOR).

Institutional Ownership by Quarter for Mazor Robotics (NASDAQ:MZOR)

Receive News & Ratings for Mazor Robotics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mazor Robotics and related companies with MarketBeat.com's FREE daily email newsletter.